NervGen Pharma (9UA.F) Q4 2024 Earnings

14NovConfirmed
Q2 2024
Q3 2024
Q4 2024
-0.07
-0.06
-0.04
-0.03

Details

Expected EPS
-0.04912923561
Actual EPS
-0.04912923561
Surprise EPS
0
Surprise Percent
+0%

Description

NervGen Pharma (9UA.F) has reported earnings of -0.04912923561 per share for Q4 2024.

0 Comments

Share your thoughts